Voiceitt for Speech Disorders

Overseen By Zara Ambadar, Ph.D

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: University of Pittsburgh

Disqualifiers: Severe cognitive impairments, aphasia, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 5-6 months

20 Participants Needed

Trial Summary

What is the purpose of this trial?

The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.

Research Team

Brad E Dicianno, MD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for individuals with speech impairments from conditions like cerebral palsy, stroke, ALS, or Parkinson's disease. The specific eligibility criteria are not provided in the given information.

Inclusion Criteria

I am 13 years old or older.

Ability to understand and follow instructions for using the Voiceitt app.

I have speech difficulties due to a condition like CP, stroke, ALS, or Parkinson's.

Exclusion Criteria

Patients who have additional speech impairments other than dysarthria, such as significant aphasia or verbal apraxia

Non-English speakers.

I understand how to use the Voiceitt app and can follow its training.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the Voiceitt app to improve communication abilities

5-6 months

Baseline visit (in-person), periodic virtual check-ins

Follow-up

Participants are monitored for changes in communication abilities and user satisfaction

2 months

Final assessment visit (in-person or virtual)

Treatment Details

Interventions

• Voiceitt

Trial Overview The study is testing the Voiceitt app's ability to help people with speech disorders communicate better. It's a pilot study aimed at assessing how feasible and effective the app is for these individuals.

Participant Groups

Group I: Voiceitt Experimental Treatment 1 Intervention

Participants will use Voiceitt App. Voiceitt is a voice recognition and dictation tool that adapts to users' unique, non-standard speech patterns. It integrates with mainstream devices and platforms to enable communication, accessibility, and independence for people with speech disabilities. https://www.voiceitt.com/

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials

1,820

Recruited

16,360,000+

Duquesne University

Collaborator

Trials

33

Recruited

2,500+